million million during I XXXX, Unless an a on a Revenue to million you, my basis. financial XX%. for quarter prepared of Gary. begin quarter will third review for third with of $XX.X or results. otherwise $XX.X was $XX.X specified Thank quarter growth compared rates year-over-year the remarks XXXX increase of all third our the referenced are of
million increase Care was Care the of prior products Revenue for of total revenue period. XX%. of XXXX, represented XX% of quarter products Revenue the $XX.X third the revenue million Advanced total $XX.X XX% compared from XXXX third compared to of million, $XX.X Advanced in XXXX, for the quarter revenue third to Wound in of or quarter Wound from year of an
amniotic Affinity the primarily for quarter despite XXXX regaining in our PuraPly in effective status two-year of products of growth to increase suspension reimbursement revenue continued in XXXX. Wound adoption The of and attributed period sales October additional first Advanced was pass-through Care a the personnel, X, the beginning
increase revenue compared Medicine of XX%. Sports XXXX expansion quarter in period. the $X.X The total & Medicine & third the to our quarter of & sales million or Surgical in year Sports to an XXXX, quarter and of of due the of prior increase for $X.X represented of from revenue was XX% Surgical third for of the products from products accounts. Sports revenue XX% total the million, penetration XXXX of $XX existing in primarily compared Medicine to Revenue force new Surgical third Revenue and was million
million from compared XX% PuraPly compared in products quarter of of quarter third third XXXX. XXXX of revenue of for in million products XX%. the Revenue third of the to revenue the for of PuraPly or total XXXX Revenue XX% $XX.X of represented total $XX.X an the increase million quarter $XX.X was from quarter to third XXXX,
at XX, agencies September approximately we XXX compared and to approximately XXX year-end of As XXX had direct XXXX, at independent representatives XXX sales to year-end. compared
XX% for in gross profit improvement was an was Gross of million of of quarter third or in for compared XX%. the Gross third The the more $XX.X primarily the third product $XX.X of a resulted quarter of third the XXXX. quarter for mix the XXXX of to of XXXX. margin quarter to favorable profit compared from XX% million revenue XXXX, XXXX for $XX.X increase third million quarter
of status for increase of to third the or $XX.X were XXXX PuraPly regaining an million, efficiencies. Operating of XXXX, million reimbursement pass-through million $XX.X manufacturing expenses quarter third volume-based and compared for XX%. quarter $XX the
of to increase increased in selling XXXX of third $XX.X administrative compared the which of operating in and XXXX, expenses, million driven in primarily as third higher or expenses to increase of XXXX million The $XX.X the million XX%. an general to compared $XX.X quarter quarter third was quarter the by
The sales selling commissions increased direct in to due revenue as primarily force, increased and products. higher expenses in headcount, general is mainly for a expenses result increase hiring sales and marketing and administrative our promotional our additional of
were for third in to our investment $X.X expenses the programs $X.X quarter compared and an million due of The new third primarily XX%. clinical million product of quarter headcount increase $X.X to R&D is in new of additional pipeline. million the and for continuing increase XXXX, or XXXX
$X.X or compared third a The in by in driven profit, XXXX in the third was operating operating of $XX.X increase increase to XX% of expenses. the XX% quarter the of operating in million loss quarter quarter of third the XX%. gross an Operating XXXX, loss a XXXX decrease for of loss was for decrease partially $X.X by million million offset
of decrease other Total for XXXX million $X.X the for quarter the or was of Net or third quarter for by was per net $X.XX quarter third third in XX%. the expense. loss $X.XX a third The compared were share decrease a of expenses XXXX, to compared million for net interest a share or of XXXX, driven a million decrease primarily decrease million $XX.X XX%. $X.X the or loss $X of of of $X.X million quarter $XX.X to per million $X.X million XXXX
third for quarter XXXX, of quarter XXXX the loss compared $X.X $X.X adjusted a The third EBITDA was loss an of XX%. EBITDA for decrease to million adjusted of million of or $X.X the million
reconciliation a this X-K, which XX-Q, results of earnings EBITDA adjusted all filed our afternoon. full Form and We our Commission have Securities with Exchange Form were provided in of release the
financial the of our of of nine million an first compared XX%. million increase was XXXX. first of months the $XXX.X months or million for of months results nine for first review for XXXX nine a to to Revenue Turning $XXX.X XXXX, the $XX.X
was XXXX for million, for or an nine Wound Care of to Wound consistent $XXX.X months million Advanced million $XXX.X year. $XX.X first revenue the nine total Revenue of XX% the of increase compared months months products from the Advanced Care the of first from with Revenue XXXX represented prior in nine revenue of of XXXX, products first XX%.
months nine first total was of revenue months months or XX% first the Sports XXXX, Revenue products from compared in for & $X.X an million months Medicine the PuraPly Revenue of for prior the products increase $XX.X to Revenue consistent million, the period. Medicine first for XXXX from products nine Surgical Sports increase & with $XX.X of represented was year for an million of to months from million of of million or first million $XX.X nine $XX.X of XX%. of the XXX%. compared XXXX first XXXX nine $XX.X XXXX, the nine Surgical
nine Revenue of first first million XX% of increase was an nine $XX.X months or from PuraPly XX%. total to million, for of months XXXX months first compared the first of products Gross in of XXXX. $XXX.X XX% in the million total compared to approximately profit of XXXX of for nine the revenue nine months revenue represented XXXX, $XX.X the
X, the from, first XX% months compared for for revenue improvement gross in efficiencies, was status XXXX. a nine result margin pass-through nine as the XXXX of strength realized margin higher the profit resulted to manufacturing primarily for months Advanced of due to October volume, reimbursement Gross period our the of two-year increased in XX% margins of first regaining Care products, sales of effective Wound The XXXX. PuraPly revenue
the for months sales nine to nine first XXXX, our expenses first Operating XX%. other in increase to or for million, first $XXX.X first months direct was million nine administrative $XXX.X fees $XXX.X ongoing as the expenses expenses selling, of general general million operating transaction. increase which of in compared the million The months and or $XX.X headcount increase XXXX due XXXX the associated XXXX an of were primarily mainly our months to the costs primarily by with offer compared $XX.X operations months expenses driven higher in consulting administrative $XXX.X and of is nine The business XXXX, of higher in exchange the increased to increase an compared nine of and first additional legal XX%. million million to of selling, and the warrant in force, hiring of
of in months $XX.X a or leverage decrease of in headcount was investment of were of the the months XX%. offset first $X.X gross was by primarily $XX.X The decrease to loss million, operating compared first loss in new clinical loss XXXX driven profit continuing an operating by nine R&D first was expenses nine XXXX, nine $X.X million to operating months million, compared first partially million XX%. for strong XXXX months of for The million nine The additional of of $XX.X million XX%. increased nine the the operating and expenses XX%, to programs. as due increase first an or XXXX $XX.X for XXXX, operating in increasing the increase months of and
in on value months or by nine the million for $X.X were of decrease Total other to first X%. of decrease the for warrants, $X.X $X.X nine the due non-cash XXXX. master primarily million penalties million, $X.X in first partially fair Silicon net decrease a compared the of lease of million new to The Bank of loss liability XXXX the upon in of a the and of decrease discount a write-off million debt expense, million underlying prepayment expenses a led $XXX $X.X by the change debt March of related XXXX, of extinguishment closure months exercise the interest was upon the of and unamortized driven of million, repayment financing $X.X to the the Valley awards offset in agreement
a loss $XX XX%. $XX.X first of per months of XX%. for of or million was of decrease months share million, EBITDA for per million, nine nine of the of million adjusted first XXXX, loss of the $X.XX $XX.X EBITDA XXXX compared million, XXXX was the loss first or months nine the a $X.XX Adjusted an loss of $XX.X nine Net first for for decrease compared $XX.X million, a to months XXXX, $XX.X or to or share net
balance to Turning sheet. the
XX, million obligations million September lease in capital obligations obligations company of $XXX.X of in of obligations $XX.X million to million which cash XXXX. of as in XX, were had capital and December $XX compared million lease XXXX, debt million in and were $XX.X which debt As cash the $XX.X $XX.X
of The cash million was cash during $X.X $XX.X for of financing activities operating net investing of in approximately million by million in activities $X.X ended million XXXX XX, by in period. and $XX.X by months offset activities, nine used the cash change used cash provided the September of driven
guidance, during review third of a outstanding to quarter warrants. I public and to of turning the review series related occurred Before to that company's XXXX transactions placement private the a our wanted
X.XXX July on The each stock XX, holders of warrants. all the an shares offer for company to Specifically made exchange common million tender. warrant XX.X was the exchange outstanding of to offer
in On of August August million XX% an we the untended X.XXXX exchange roughly On the XX, shares ratio issuance warrants shares XX.XX were we of public another issued share. announced million outstanding XX, resulted remaining at of tendered for the warrants, all expiration stock. X.X per the that date warrants offer of XX,XXX of which public exchange common
common private of obligations million warrants We in X.X series million stock resulted of also of our the the outstanding issuance outstanding Together, third quarter, in us common during period. the retire issued for the which X.X shares exchange in placement of period. during XXX,XXX transactions shares the stock warrant all allowed an to of
the our We or at dilution such roughly overhang point The after a shares prudent issued represented the they warrants and removed of approximately dilution nearly these dilution the structure. a X.X% executed if shares XX% XX.X the some avoids overall issuances, dilution as of million improved but transactions warrant future. capital, per significant believe were potential were terms use original in capital
release of XXXX review updated our a our afternoon. this revenue to which earnings guidance, Turning we in
million, million million and XX revenue XX% for XX, representing to company's XXXX The of growth forecast between revenue ended XX% compared December now between million of at representing Wound to and for which company XX and called products $XXX XXXX, revenue $XXX total prior months the XXXX the the of growth revenue of in from approximately range updated approximately Care of $XXX $XXX year-over-year. $XXX.X Advanced million, between guidance year-over-year range the assumes the For XX% XX, revenue the ended months $XXX $XXX of as XXXX. expects midpoint and million now million December
the of million million XXXX of as between updated of to guidance million for called Surgical and to ended and million XXXX. company's which XX, revenue The revenue $XX $XX.X Medicine revenue the XX months range, $XX growth for year-over-year, assumes, $XX XX% approximately in forecast between December revenue $XX compared representing & from prior Sports also and of XX% products XXXX million
called XXXX guidance updated guidance of for to as for range range and will PuraPly December compared growth assumes million from now XX company's XXXX. XX, prior $XXX with revenue million sale the and $XXX million $XXX the in months of revenue between $XX.X of our million that revenue Finally, to approximately and the between products year-over-year, XX% the represent ended revenue representing XX% $XXX XXXX million,
Gary? over Gary. back turn I'll to that, the With call